Issue Date |
Title |
Author(s) |
30-Jan-2023 |
Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy |
Bi, Xiaoyue;Xie, Si;Wu, Shuling;Cao, Weihua;Lin, Yanjie;Yang, Liu;Jiang, Tingting;Deng, Wen;Wang, Shiyu;Liu, Ruyu;Gao, Yuanjiao;Shen, Ge;Chang, Min;Hao, Hongxiao;Xu, Mengjiao;Chen, Xiaoxue;Hu, Leiping;Lu, Yao;Zhang, Lu;Xie, Yao;Li, Minghui |
27-Jan-2021 |
The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy |
Cao, Weihua;Li, Minghui;Zhang, Lu;Lu, Yao;Wu, Shuling;Shen, Ge;Chang, Min;Liu, Ruyu;Gao, Yuanjiao;Hao, Hongxiao;Hu, Leiping;Yi, Wei;Pan, Calvin Q.;Xie, Yao |
24-Oct-2022 |
Cytokine profiles and CD8+T cells in the occurrence of acute and chronic hepatitis B |
Xie, Si;Yang, Liu;Bi, Xiaoyue;Deng, Wen;Jiang, Tingting;Lin, Yanjie;Wang, Shiyu;Zhang, Lu;Liu, Ruyu;Chang, Min;Wu, Shuling;Gao, Yuanjiao;Hao, Hongxiao;Shen, Ge;Xu, Mengjiao;Chen, Xiaoxue;Hu, Leiping;Lu, Yao;Song, Rui;Xie, Yao;Li, Minghui |
20-Sep-2022 |
Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B |
Li, Minghui;Gao, Yuanjiao;Yang, Liu;Lin, Yanjie;Deng, Wen;Jiang, Tingting;Bi, Xiaoyue;Lu, Yao;Zhang, Lu;Shen, Ge;Liu, Ruyu;Wu, Shuling;Chang, Min;Xu, Mengjiao;Hu, Leiping;Song, Rui;Jiang, Yuyong;Yi, Wei;Xie, Yao |
24-Jan-2023 |
Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment |
Lin, Yanjie;Shen, Ge;Xie, Si;Bi, Xiaoyue;Lu, Huihui;Yang, Liu;Jiang, Tingting;Deng, Wen;Wang, Shiyu;Zhang, Lu;Lu, Yao;Gao, Yuanjiao;Hao, Hongxiao;Wu, Shuling;Liu, Ruyu;Chang, Min;Xu, Mengjiao;Hu, Leiping;Chen, Xiaoxue;Huang, Ronghai;Li, Minghui;Xie, Yao |
16-Feb-2023 |
Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity |
Lu, Huihui;Cao, Weihua;Zhang, Luxue;Yang, Liu;Bi, Xiaoyue;Lin, Yanjie;Deng, Wen;Jiang, Tingting;Sun, Fangfang;Zeng, Zhan;Lu, Yao;Zhang, Lu;Liu, Ruyu;Gao, Yuanjiao;Wu, Shuling;Hao, Hongxiao;Chen, Xiaoxue;Hu, Leiping;Xu, Mengjiao;Xiong, Qiqiu;Dong, Jianping;Song, Rui;Li, Minghui;Xie, Yao |
21-Nov-2022 |
Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN alpha-2a therapy |
Cao, Weihua;Lu, Huihui;Zhang, Luxue;Wang, Shiyu;Deng, Wen;Jiang, Tingting;Lin, Yanjie;Yang, Liu;Bi, Xiaoyue;Lu, Yao;Zhang, Lu;Shen, Ge;Liu, Ruyu;Chang, Min;Wu, Shuling;Gao, Yuanjiao;Hao, Hongxiao;Xu, Mengjiao;Chen, Xiaoxue;Hu, Leiping;Xie, Yao;Li, Minghui |
19-Jan-2023 |
A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L |
Zhang, Lu;Bi, Xiaoyue;Chen, Xiaoxue;Zhang, Luxue;Xiong, Qiqiu;Cao, Weihua;Lin, Yanjie;Yang, Liu;Jiang, Tingting;Deng, Wen;Wang, Shiyu;Wu, Shuling;Liu, Ruyu;Gao, Yuanjiao;Shen, Ge;Chang, Min;Hao, Hongxiao;Xu, Mengjiao;Hu, Leiping;Lu, Yao;Li, Minghui;Xie, Yao |
4-Jan-2023 |
Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection |
Zhang, Lu;Jiang, Tingting;Yang, Ying;Deng, Wen;Lu, Huihui;Wang, Shiyu;Liu, Ruyu;Chang, Min;Wu, Shuling;Gao, Yuanjiao;Hao, Hongxiao;Shen, Ge;Xu, Mengjiao;Chen, Xiaoxue;Hu, Leiping;Yang, Liu;Bi, Xiaoyue;Lin, Yanjie;Lu, Yao;Jiang, Yuyong;Li, Minghui;Xie, Yao |
16-Jun-2022 |
Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report |
Wu, Shuling;Bi, Xiaoyue;Lin, Yanjie;Yang, Liu;Li, Minghui;Xie, Yao |